BG102812A - SOLID DOSED OUT FORM OF CISAPRID HAVING IMMEDIATE RELEASE INDEPENDENT OF pH - Google Patents
SOLID DOSED OUT FORM OF CISAPRID HAVING IMMEDIATE RELEASE INDEPENDENT OF pHInfo
- Publication number
- BG102812A BG102812A BG102812A BG10281298A BG102812A BG 102812 A BG102812 A BG 102812A BG 102812 A BG102812 A BG 102812A BG 10281298 A BG10281298 A BG 10281298A BG 102812 A BG102812 A BG 102812A
- Authority
- BG
- Bulgaria
- Prior art keywords
- cisaprid
- out form
- immediate release
- dosed out
- release independent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96201078 | 1996-04-23 | ||
PCT/EP1997/001462 WO1997039744A1 (en) | 1996-04-23 | 1997-03-20 | Immediate release ph-independent solid dosage form of cisapride |
Publications (1)
Publication Number | Publication Date |
---|---|
BG102812A true BG102812A (en) | 1999-05-31 |
Family
ID=8223900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG102812A BG102812A (en) | 1996-04-23 | 1998-10-01 | SOLID DOSED OUT FORM OF CISAPRID HAVING IMMEDIATE RELEASE INDEPENDENT OF pH |
Country Status (23)
Country | Link |
---|---|
US (1) | US6030988A (xx) |
JP (1) | JPH10510559A (xx) |
KR (1) | KR100204115B1 (xx) |
CN (1) | CN1216467A (xx) |
AR (1) | AR006790A1 (xx) |
AT (1) | ATE220543T1 (xx) |
AU (1) | AU720582B2 (xx) |
BG (1) | BG102812A (xx) |
BR (1) | BR9708585A (xx) |
CA (1) | CA2201264C (xx) |
CZ (1) | CZ332598A3 (xx) |
DE (1) | DE69713948D1 (xx) |
EA (1) | EA000804B1 (xx) |
EE (1) | EE03552B1 (xx) |
ID (1) | ID16666A (xx) |
IL (1) | IL125979A0 (xx) |
NO (1) | NO984016L (xx) |
NZ (1) | NZ331705A (xx) |
PL (1) | PL328917A1 (xx) |
SK (1) | SK144698A3 (xx) |
TR (1) | TR199802139T2 (xx) |
WO (1) | WO1997039744A1 (xx) |
ZA (1) | ZA973449B (xx) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6489346B1 (en) * | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US20030138485A1 (en) * | 1998-01-14 | 2003-07-24 | Daiichi Pharmaceutical Co., Ltd. | Disintegrant |
ES2373864T3 (es) * | 1998-04-20 | 2012-02-09 | Eisai R&D Management Co., Ltd. | Composición estabilizada que contiene un compuesto de tipo bencimidazol. |
TW407058B (en) * | 1998-07-17 | 2000-10-01 | Dev Center Biotechnology | Oral cisapride dosage forms with an extended duration |
US6353005B1 (en) * | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
US7220762B1 (en) | 1999-10-20 | 2007-05-22 | Eisai R&D Management Co., Ltd. | Methods for stabilizing benzimidazole compounds |
GB0001621D0 (en) * | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
SE0100200D0 (sv) * | 2001-01-24 | 2001-01-24 | Astrazeneca Ab | New film coating |
US7714006B1 (en) | 2001-12-03 | 2010-05-11 | King Pharmaceuticals Research & Development, Inc. | Methods of modifying the bioavailability of metaxalone |
US6407128B1 (en) | 2001-12-03 | 2002-06-18 | Elan Pharmaceuticals, Inc. | Method for increasing the bioavailability of metaxalone |
DE10164510A1 (de) * | 2001-12-20 | 2003-07-10 | Schering Ag | Orale Fludara reinst Formulierung mit schneller Freisetzung des Wirkstoffes |
EP1321142A1 (en) * | 2001-12-21 | 2003-06-25 | Novartis AG | Solid pharmaceutical composition for oral administration of Tegaserod |
HRP20020124A2 (en) * | 2002-02-11 | 2003-10-31 | Pliva D D | Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping |
GB2390541A (en) * | 2002-07-12 | 2004-01-14 | Reckitt Benckiser Healthcare | Medicinal composition comprising fibre or saccharide bulking agents |
WO2004019937A1 (en) * | 2002-09-02 | 2004-03-11 | Sun Pharmaceutical Industries Limited | Pharmaceutical composition of metaxalone with enhanced oral bioavailability |
US20050220870A1 (en) * | 2003-02-20 | 2005-10-06 | Bonnie Hepburn | Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid |
US8993599B2 (en) * | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
TWI398273B (zh) * | 2003-07-18 | 2013-06-11 | Santarus Inc | 用於抑制酸分泌之醫藥調配物及其製備及使用之方法 |
TWI337877B (en) * | 2003-07-18 | 2011-03-01 | Santarus Inc | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders |
US20070292498A1 (en) * | 2003-11-05 | 2007-12-20 | Warren Hall | Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers |
US8138204B2 (en) * | 2004-01-07 | 2012-03-20 | Aryx Therapeutics, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
US8524736B2 (en) | 2004-01-07 | 2013-09-03 | Armetheon, Inc. | Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders |
CA2554271A1 (en) * | 2004-02-10 | 2005-08-25 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent |
MXPA06011820A (es) * | 2004-04-16 | 2006-12-15 | Santarus Inc | Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico. |
US8815916B2 (en) * | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) * | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
CA2609192A1 (en) | 2005-05-26 | 2006-11-30 | Duramed Pharmaceuticals, Inc. | Oral dosage forms comprising progesterone and methods of making and using the same |
CN1935264B (zh) * | 2005-09-23 | 2010-05-05 | 北京德众万全医药科技有限公司 | 一种用于缓控释片的含有hpmc的新型复合辅料 |
US20090092658A1 (en) * | 2007-10-05 | 2009-04-09 | Santarus, Inc. | Novel formulations of proton pump inhibitors and methods of using these formulations |
TW200843802A (en) * | 2007-02-09 | 2008-11-16 | Drugtech Corp | Compositions for improving gastrointestinal nutrient and drug absorption |
CN104352465B (zh) * | 2014-11-17 | 2017-04-12 | 成都新恒创药业有限公司 | 一种不含二氧化硅的琥珀酸普芦卡必利药物组合物及其制备方法 |
CN109394711A (zh) * | 2018-11-06 | 2019-03-01 | 威海贯标信息科技有限公司 | 一种酒石酸西尼必利片组合物 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4962115A (en) * | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
JPH08502032A (ja) * | 1992-07-07 | 1996-03-05 | セプラコア インコーポレーテッド | 胃食道逆流疾患およびその他の障害を治療するために▲(−)▼シサプリドを使用する方法 |
JPH08502031A (ja) * | 1992-07-07 | 1996-03-05 | セプラコア インコーポレーテッド | 胃食道逆流疾患およびその他の障害を治療するために▲(+)▼シサプリドを使用する方法 |
EP0707492A1 (en) * | 1993-07-06 | 1996-04-24 | Merck & Co. Inc. | H 2? antagonist-gastrointestinal motility agent combinations |
ATE182073T1 (de) * | 1994-03-01 | 1999-07-15 | Gerhard Gergely | Ein brausesystem und einen arzneiwirkstoff enthaltendes granuläres produkt bzw. tablette sowie verfahren zu deren herstellung |
CH686865A5 (de) * | 1994-06-15 | 1996-07-31 | Gergely Gerhard | Pharmazeutische Zubereitung mit einem hydrophoben Wirkstoff und einem Brausesystem, sowie Verfahren zur Herstellung der Zubereitung. |
ZA959221B (en) * | 1994-11-02 | 1997-04-30 | Janssen Pharmaceutica Nv | Cisapride extended release |
-
1997
- 1997-03-11 DE DE69713948T patent/DE69713948D1/de not_active Expired - Lifetime
- 1997-03-11 AT AT97200715T patent/ATE220543T1/de not_active IP Right Cessation
- 1997-03-20 TR TR1998/02139T patent/TR199802139T2/xx unknown
- 1997-03-20 SK SK1446-98A patent/SK144698A3/sk unknown
- 1997-03-20 US US08/821,151 patent/US6030988A/en not_active Expired - Fee Related
- 1997-03-20 EE EE9800269A patent/EE03552B1/xx not_active IP Right Cessation
- 1997-03-20 JP JP9537646A patent/JPH10510559A/ja active Pending
- 1997-03-20 WO PCT/EP1997/001462 patent/WO1997039744A1/en not_active Application Discontinuation
- 1997-03-20 CN CN97193987A patent/CN1216467A/zh active Pending
- 1997-03-20 PL PL97328917A patent/PL328917A1/xx unknown
- 1997-03-20 BR BR9708585A patent/BR9708585A/pt not_active IP Right Cessation
- 1997-03-20 CZ CZ983325A patent/CZ332598A3/cs unknown
- 1997-03-20 AU AU22904/97A patent/AU720582B2/en not_active Ceased
- 1997-03-20 IL IL12597997A patent/IL125979A0/xx unknown
- 1997-03-20 NZ NZ331705A patent/NZ331705A/xx unknown
- 1997-03-20 EA EA199800861A patent/EA000804B1/ru not_active IP Right Cessation
- 1997-03-27 CA CA002201264A patent/CA2201264C/en not_active Expired - Fee Related
- 1997-04-08 KR KR1019970012865A patent/KR100204115B1/ko not_active IP Right Cessation
- 1997-04-22 AR ARP970101627A patent/AR006790A1/es unknown
- 1997-04-22 ID IDP971336A patent/ID16666A/id unknown
- 1997-04-22 ZA ZA973449A patent/ZA973449B/xx unknown
-
1998
- 1998-09-01 NO NO984016A patent/NO984016L/no not_active Application Discontinuation
- 1998-10-01 BG BG102812A patent/BG102812A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CZ332598A3 (cs) | 1999-01-13 |
EA199800861A1 (ru) | 1999-02-25 |
KR100204115B1 (ko) | 1999-06-15 |
ATE220543T1 (de) | 2002-08-15 |
ZA973449B (en) | 1998-10-22 |
JPH10510559A (ja) | 1998-10-13 |
SK144698A3 (en) | 1999-05-07 |
BR9708585A (pt) | 1999-08-03 |
DE69713948D1 (de) | 2002-08-22 |
CN1216467A (zh) | 1999-05-12 |
KR970069038A (ko) | 1997-11-07 |
AU720582B2 (en) | 2000-06-08 |
NO984016D0 (no) | 1998-09-01 |
PL328917A1 (en) | 1999-03-01 |
CA2201264A1 (en) | 1997-10-23 |
AR006790A1 (es) | 1999-09-29 |
US6030988A (en) | 2000-02-29 |
EE03552B1 (et) | 2001-12-17 |
EA000804B1 (ru) | 2000-04-24 |
TR199802139T2 (xx) | 1999-03-22 |
CA2201264C (en) | 1999-08-10 |
NO984016L (no) | 1998-12-23 |
WO1997039744A1 (en) | 1997-10-30 |
AU2290497A (en) | 1997-11-12 |
ID16666A (id) | 1997-10-30 |
IL125979A0 (en) | 1999-04-11 |
EE9800269A (et) | 1999-02-15 |
NZ331705A (en) | 1999-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG102812A (en) | SOLID DOSED OUT FORM OF CISAPRID HAVING IMMEDIATE RELEASE INDEPENDENT OF pH | |
ATE290391T1 (de) | Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen | |
DE60018100D1 (en) | Polymorphe form von atorvastatin-calcium | |
DE60122767D1 (de) | Indoly-lsulphonyl-verbindungen zur behandlung von störungen des zns | |
TW252038B (xx) | ||
BG104356A (en) | Compounds based on azabenzimidazole for the modulation of serin/treonin protein kinase function | |
HK1050627A1 (en) | Phosphonate compounds | |
BG102726A (en) | Combined therapy for osteoporosis | |
BG101966A (en) | Application of 1l-agonist for the treatment of lack of urine retention | |
GB0111186D0 (en) | Novel compounds | |
IL140419A0 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
MXPA03010549A (es) | Formas de dosificacion de oxcarbazepina. | |
DE69827684D1 (de) | Neue Lactobazillus-Stämme zur Behandlung von Störungen des Gastrointestinaltraktes | |
NZ521516A (en) | Nutritional mineral fortification of milk by adding an orthophosphate and either a soluble calcium or other nutritional mineral | |
BG106391A (en) | Use of cgrp antagonists and cgrp release inhibitors for controlling menopausal hot flashes | |
HK1023770A1 (en) | Chalcones having antiproliferative activity. | |
PL329413A1 (en) | Chemical compounds exhibiting properties capable to cause growth hormone release | |
MXPA04000446A (es) | 4-aminociclohexanoles sustituidos. | |
MXPA02007903A (es) | Uso de acido 2-metil-tiazolidina-2, 4-dicarboxilico (2-mtdc) y/o sales fisiologicamente compatibles para tratar y/o prevenir canceres. | |
MXPA02012857A (es) | Uso de una formulacion elaborada de o que contiene al menos un suero de leche dismilado. | |
DE69715644D1 (de) | VERWENDUNGEN VON alpha-LACTALBUMIN ZUSAMMENSETZUNGEN | |
BR0012973B1 (pt) | Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica. | |
PL345204A1 (en) | Compounds with growth hormone releasing properties | |
HK1023516A1 (en) | Pharmaceutical composition containing stimulators of interferon-gamma | |
WO2000047192A3 (de) | UBICHINON Qn ZUR BEHANDLUNG VON SCHMERZEN |